Published in Volume
91, Issue 3 (March 1993)
J Clin Invest. 1993;91(3):1241–1246.
doi:10.1172/JCI116287.
Copyright ©
1993, The American Society for
Clinical Investigation.
Research Article
Targeted transfection and expression of hepatitis B viral DNA in human hepatoma cells.
T J Liang, W J Makdisi, S Sun, K Hasegawa, Y Zhang, J R Wands, C H Wu and G Y Wu
Gastrointestinal Unit, Medical Services, Massachusetts General Hospital, Boston 02114.
Published March 1993
A soluble DNA carrier system consisting of an asialoglycoprotein covalently linked to poly-L-lysine was used to bind DNA and deliver hepatitis B virus (HBV) DNA constructs to asialoglycoprotein receptor-positive human hepatoma cells. 4 d after transfection with surface or core gene expression constructs, HBsAg and HBeAg in the media were measured to be 16 ng/ml and 32 U/ml per 10(7) cells, respectively. Antigen production was completely inhibited by the addition of an excess of asialoorosomucoid. On the other hand, asialoglycoprotein receptor-negative human hepatoma cells, SK-Hep1, did not produce any viral antigens under identical conditions after incubation with HBV DNA complexed to a conjugate composed of asialoorosomucoid and poly-L-lysine. Using a complete HBV genome construct, HBsAg and HBeAg levels reached 16 ng/ml and 16 U/ml per 10(7) cells, respectively. Northern blots revealed characteristic HBV RNA transcripts including 3.5-, 2.4-, and 2.1-kb fragments. Intracellular and extracellular HBV DNA sequences including relaxed circular, linear and single stranded forms were detected by Southern blot hybridization. Finally, 42-nm Dane particles purified from the spent cultures medium were visualized by electron microscopy. This study demonstrates that a targetable DNA carrier system can transfect HBV DNA in vitro resulting in the production of complete HBV virions.
Browse pages
Click on an image below to see the page. View
PDF of the complete article